ACHROMOBACTER

Clinical trials for ACHROMOBACTER explained in plain language.

Never miss a new study

Get alerted when new ACHROMOBACTER trials appear

Sign up with your email to follow new studies for ACHROMOBACTER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Virus vs. superbug: new weapon tested for cystic fibrosis lung infections

Disease control Not yet recruiting

This early-stage study is testing whether adding a special virus treatment to standard antibiotics is safe and helpful for adults with cystic fibrosis who have hard-to-treat lung infections. Up to 30 participants will receive a 7-day course of antibiotics plus a custom-made cockt…

Matched conditions: ACHROMOBACTER

Phase: PHASE1 • Sponsor: University of California, San Diego • Aim: Disease control

Last updated Apr 02, 2026 05:12 UTC

ACHROMOBACTER

Get alerted when new ACHROMOBACTER trials appear

Virus vs. superbug: new weapon tested for cystic fibrosis lung infections